J.P. Morgan on Wednesday launched its coverage of ANI Pharmaceuticals (NASDAQ:ANIP) with an Overweight recommendation and a ...

Jefferies initiated coverage of ANI Pharmaceuticals (ANIP) with a Buy rating and $80 price target The firm expects continued momentum for the ...

Does storing copyrighted material amount to infringement? Read what the amicus curiae in the ANI vs OpenAI case said about ...

This year's best picture winner at the Oscars starts out as a kind of romantic comedy, but things get real pretty quick.

Fintel reports that on March 14, 2025, Jefferies initiated coverage of ANI Pharmaceuticals (NasdaqGM:ANIP) with a Buy ...

The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...

The jewelry company owes Love $6 million in royalties, and more than $200,000 in unpaid consulting fees, the suit says.

JPMorgan initiated coverage of ANI Pharmaceuticals (ANIP) with an Overweight rating and $85 price target ANI is a specialty pharmaceuticals ...